# Trial to Assess the Efficacy and Safety During Convective Radiofrequency Water Vapor Thermal Therapy (REZUM) for Benign Prostate Hyperplasia

> **NCT07017452** · PHASE3 · NOT_YET_RECRUITING · sponsor: **University of Manitoba** · enrollment: 48 (estimated)

## Conditions studied

- Benign Prostate Hypertrophy(BPH)

## Interventions

- **DRUG:** Methoxyflurane - Penthrox
- **OTHER:** Control
- **DRUG:** Percocet Pill
- **DRUG:** Lorazepam (drug)

## Key facts

- **NCT ID:** NCT07017452
- **Lead sponsor:** University of Manitoba
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-08
- **Primary completion:** 2025-12
- **Final completion:** 2026-06
- **Target enrollment:** 48 (ESTIMATED)
- **Last updated:** 2025-06-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07017452

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07017452, "Trial to Assess the Efficacy and Safety During Convective Radiofrequency Water Vapor Thermal Therapy (REZUM) for Benign Prostate Hyperplasia". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT07017452. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*